Startup Beats $460M Cancer Trade Secrets Case In Delaware

In front of a federal jury in Delaware, a California biotech startup has defeated a nearly $460 million trade secrets case from a rival that claimed the startup's co-founder helped himself...

Already a subscriber? Click here to view full article